GM2-KLH vaccine
Term · Oncology and biomedicine · MLC-T-ONC-003604
A substance used to stimulate the production of antibodies that fight certain cancer cells.
A cancer vaccine consisting of GM2 ganglioside, a melanoma-specific antigen, conjugated with the immunostimulant keyhole limpet hemocyanin. Vaccination with GM2-KLH vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against GM2 ganglioside-expressing melanoma cells, resulting in tumor growth inhibition.
| Identifier | MLC-T-ONC-003604 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | GM2-KLH |
| Synonyms | GM2-KLH ganglioside; KLH-conjugated GM2 Ganglioside Vaccine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-003604",
"term": "GM2-KLH vaccine",
"field": "Oncology and biomedicine",
"definitions": [
"A substance used to stimulate the production of antibodies that fight certain cancer cells.",
"A cancer vaccine consisting of GM2 ganglioside, a melanoma-specific antigen, conjugated with the immunostimulant keyhole limpet hemocyanin. Vaccination with GM2-KLH vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against GM2 ganglioside-expressing melanoma cells, resulting in tumor growth inhibition."
],
"abbreviation": "GM2-KLH",
"synonyms": [
"GM2-KLH ganglioside",
"KLH-conjugated GM2 Ganglioside Vaccine"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/gm2-klh-vaccine/"
}
Record 8,086 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.